Alfa Laval wins record biofuel order, shares in focus on Stockholm
29.06.2026 - 09:12:30 | ad-hoc-news.de
By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-29, 09:12.
Alfa Laval (SE0000695876) today announced a record 1.1 billion Swedish kronor contract to supply Hydrotreated Vegetable Oil pre-treatment technology to Acelen's new biorefinery project in Brazil, as detailed in a June 29 company release. The PRNewswire-distributed Alfa Laval statement confirms that the Stockholm-listed company will deliver the equipment in phases through 2029.
Record biorefinery contract in Brazil
The order, valued at 1.1 billion kronor or about 102 million euros, is described by Alfa Laval as the largest single order ever signed in the group's history, highlighting a marked expansion of its biofuel footprint. The official Alfa Laval investor relations press release states that the Hydrotreated Vegetable Oil pre-treatment technology will be deployed at Acelen's planned biorefinery in Brazil, with completion of the project expected in 2029.
The Brazilian facility is designed to process bio-based feedstock into advanced renewable fuels, and the Alfa Laval equipment will be delivered in several phases over the coming years, linking revenue recognition to project milestones. The PRNewswire announcement emphasizes that the contract reinforces Alfa Laval's strategic ambition to support the energy transition by supplying high-efficiency thermal and separation technologies to large-scale sustainable fuel projects.
Energy transition strategy and sector peers
Alfa Laval positions the Brazil biorefinery contract squarely within its broader energy transition strategy, which focuses on providing heat transfer, separation and fluid handling solutions to decarbonization projects across biofuels, hydrogen and carbon capture. The group's documented strategy and financial targets highlight renewable energy and circular solutions as priority growth areas alongside marine and industrial applications.
In the diversified industrial and process technology space, Alfa Laval competes and collaborates with sector peers such as GEA Group and SPX FLOW in providing critical equipment for food processing, chemicals and energy, while its move into large-scale Hydrotreated Vegetable Oil projects underscores a closer alignment with biofuel value chains that also involve energy majors and agricultural groups. Reuters coverage of expanding global biofuels investment points to a rising pipeline of HVO and sustainable aviation fuel projects worldwide, providing a deeper backdrop for Alfa Laval's order intake.
All news and analysis on the Alfa Laval shares
Further coverage, price data and background information on the Alfa Laval shares are available on the ad-hoc-news.de topic page and via the company's investor relations portal.
The product behind the stock
At the center of the Brazilian biorefinery order is Alfa Laval's Hydrotreated Vegetable Oil pre-treatment technology, a system designed to clean and condition bio-based feedstocks by removing contaminants and optimizing process efficiency before hydrotreatment, enabling the production of advanced renewable diesel and related fuels in high-capacity plants.
Where the stock trades today
The Alfa Laval shares (SE0000695876) trade on Nasdaq Stockholm, and on 2026-06-29, 09:00 they were last quoted at 320.00 Swedish kronor.
Key data on the Alfa Laval shares
- Company: Alfa Laval AB
- ISIN: SE0000695876
- WKN: A0D9C5
- Ticker: ALFA
- Trading venue: Nasdaq Stockholm
- Price (as of 2026-06-29, 09:00): 320.00 SEK
- Market cap: 132.0 billion SEK (as of 2026-06-29)
- Sector / industry: Industrials / Industrial machinery
- Index membership: OMX Stockholm 30
- Next earnings date: 2026-07-17
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or any form of financial guidance. All data and assessments are based on sources deemed reliable at the time of publication, but no warranty is given for completeness or accuracy. Investors should conduct their own research or consult a qualified advisor before making investment decisions.
